These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 35661084)

  • 21. Recent Advances in Biocompatible Ionic Liquids in Drug Formulation and Delivery.
    Moshikur RM; Carrier RL; Moniruzzaman M; Goto M
    Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipophilic Salts and Lipid-Based Formulations for Bridging the Food Effect Gap of Venetoclax.
    Koehl NJ; Henze LJ; Holm R; Kuentz M; Keating JJ; De Vijlder T; Marx A; Griffin BT
    J Pharm Sci; 2022 Jan; 111(1):164-174. PubMed ID: 34516990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmaceutical Applications of Ionic Liquids: A Personal Account.
    Md Moshikur R; Goto M
    Chem Rec; 2023 Aug; 23(8):e202300026. PubMed ID: 37042429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipolysis-Permeation Setup for Simultaneous Study of Digestion and Absorption in Vitro.
    Keemink J; Mårtensson E; Bergström CAS
    Mol Pharm; 2019 Mar; 16(3):921-930. PubMed ID: 30628771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction with biliary and pancreatic fluids drives supersaturation and drug absorption from lipid-based formulations of low (saquinavir) and high (fenofibrate) permeability poorly soluble drugs.
    Suys EJA; Brundel DHS; Chalmers DK; Pouton CW; Porter CJH
    J Control Release; 2021 Mar; 331():45-61. PubMed ID: 33450318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Role of Ionic Liquids in the Pharmaceutical Field: An Overview of Relevant Applications.
    Pedro SN; R Freire CS; Silvestre AJD; Freire MG
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ionic liquids in drug delivery.
    Shamshina JL; Barber PS; Rogers RD
    Expert Opin Drug Deliv; 2013 Oct; 10(10):1367-81. PubMed ID: 23795613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of gastrointestinal lipolysis on oral lipid-based formulations and bioavailability of lipophilic drugs.
    Carrière F
    Biochimie; 2016 Jun; 125():297-305. PubMed ID: 26607242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro assessment of drug-free and fenofibrate-containing lipid formulations using dispersion and digestion testing gives detailed insights into the likely fate of formulations in the intestine.
    Devraj R; Williams HD; Warren DB; Mohsin K; Porter CJ; Pouton CW
    Eur J Pharm Sci; 2013 Jul; 49(4):748-60. PubMed ID: 23684915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Choline- versus imidazole-based ionic liquids as functional ingredients in topical delivery systems: cytotoxicity, solubility, and skin permeation studies.
    Santos de Almeida T; Júlio A; Saraiva N; Fernandes AS; Araújo MEM; Baby AR; Rosado C; Mota JP
    Drug Dev Ind Pharm; 2017 Nov; 43(11):1858-1865. PubMed ID: 28665154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transformation of Biopharmaceutical Classification System Class I and III Drugs Into Ionic Liquids and Lipophilic Salts for Enhanced Developability Using Lipid Formulations.
    Williams HD; Ford L; Lim S; Han S; Baumann J; Sullivan H; Vodak D; Igonin A; Benameur H; Pouton CW; Scammells PJ; Porter CJH
    J Pharm Sci; 2018 Jan; 107(1):203-216. PubMed ID: 28549907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Lipid Digestion and Drug Permeation/Re-Dissolution on Absorption of Orally Administered Ritonavir as Different Lipid-Based Formulations.
    Tanaka Y; Doi H; Katano T; Kasaoka S
    Eur J Pharm Sci; 2021 Feb; 157():105604. PubMed ID: 33098990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 'Pro et contra' ionic liquid drugs - Challenges and opportunities for pharmaceutical translation.
    Balk A; Holzgrabe U; Meinel L
    Eur J Pharm Biopharm; 2015 Aug; 94():291-304. PubMed ID: 26070389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ionic liquids provide unique opportunities for oral drug delivery: structure optimization and in vivo evidence of utility.
    Williams HD; Sahbaz Y; Ford L; Nguyen TH; Scammells PJ; Porter CJ
    Chem Commun (Camb); 2014 Feb; 50(14):1688-90. PubMed ID: 24394756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Digestion of Lipid-Based Formulations Not Only Mediates Changes to Absorption of Poorly Soluble Drugs Due to Differences in Solubilization But Also Reflects Changes to Thermodynamic Activity and Permeability.
    Tanaka Y; Nguyen TH; Suys EJA; Porter CJH
    Mol Pharm; 2021 Apr; 18(4):1768-1778. PubMed ID: 33729806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ionic liquids as ingredients in topical drug delivery systems.
    Dobler D; Schmidts T; Klingenhöfer I; Runkel F
    Int J Pharm; 2013 Jan; 441(1-2):620-7. PubMed ID: 23123180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ionization basis for activation of enzymes soluble in ionic liquids.
    Ou G; He B; Halling P
    Biochim Biophys Acta; 2016 Jul; 1860(7):1404-8. PubMed ID: 27060372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ionic liquids as a useful tool for tailoring active pharmaceutical ingredients.
    Wu X; Zhu Q; Chen Z; Wu W; Lu Y; Qi J
    J Control Release; 2021 Oct; 338():268-283. PubMed ID: 34425167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of Gastrointestinal Mucus Properties with Ionic Liquids for Drug Delivery.
    Peng K; Gao Y; Angsantikul P; LaBarbiera A; Goetz M; Curreri AM; Rodrigues D; Tanner EEL; Mitragotri S
    Adv Healthc Mater; 2021 Jul; 10(13):e2002192. PubMed ID: 34050617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancing intestinal drug solubilisation using lipid-based delivery systems.
    Porter CJ; Pouton CW; Cuine JF; Charman WN
    Adv Drug Deliv Rev; 2008 Mar; 60(6):673-91. PubMed ID: 18155801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.